Innovative Tool to Limit Spread of COVID 19 in Residential Aged Care Facilities
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04377165|
Recruitment Status : Terminated (Engagement issues, poor recruitment to study)
First Posted : May 6, 2020
Last Update Posted : March 9, 2021
|Condition or disease||Intervention/treatment||Phase|
|COVID Influenza Gastroenteritis||Behavioral: Gamification Behavioral: Newsfeed function||Not Applicable|
The study design will be a multi- centre cluster randomised control trial, where Age Care facilities are randomised into two groups:
- Newsfeed- gets the app with newsfeed only
- Gamification group- gets the full gamified app, including the newsfeed Workers in our network of residential aged care facilities will be invited to participate in a study of communication of information regarding COVID-19 and how they will play a role in preventing its spread.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||34 participants|
|Intervention Model:||Sequential Assignment|
|Masking:||None (Open Label)|
|Official Title:||Innovative Tool to Limit Spread of COVID 19 in Residential Aged Care|
|Actual Study Start Date :||May 6, 2020|
|Actual Primary Completion Date :||August 26, 2020|
|Actual Study Completion Date :||August 26, 2020|
Active Comparator: Newsfeed
This will provide you with reliable accurate information on the pandemic.
Behavioral: Newsfeed function
This will provide the user with reliable accurate information on the pandemic.
The gamification function will allow users to earn points for actions completed. The gamification function has links to resources for infection control, watching or completing tasks or playing games to earn points. Points can be viewed at a facility level, state level or national level.
This will provide the user with the newsfeed function and the addition of a gamification function
- To compare the hours of sick leave used over the course of the 4-week period post randomisation for each group [ Time Frame: 4 weeks ]Compare the number of sick leave prior to users utilising the app and at the end of the 4 weeks between the arms
- To compare handwashing behaviour [ Time Frame: 4 weeks ]Compare the amount of soap/sanitiser used between the arms
- To compare self-testing rates [ Time Frame: 4 weeks ]Compare the number of self tests between the two arms
- To compare the level of surface wipe down [ Time Frame: 4 weeks ]Compare the amount of wipes/disinfectant used between the two arms
- To compare number of COVID-19 tests completed in Facilities [ Time Frame: 4 weeks ]Compare the number of COVID-19 tests between the two arms
- To compare the number of COVID 19 infections in facilities [ Time Frame: 4 weeks ]Compare the number of COVID-19 infections between the arms
- To compare the other types of outbreaks (Flu, gastroenteritis) [ Time Frame: 4 weeks ]Compare the number of flu and gastroenteritis outbreaks between the arms
- To compare the awareness of COVID 19 training available to workers in the facilities [ Time Frame: 4 weeks ]Compare the COVID 19 training between the two arms, this is via a self reported survey
- To compare the awareness of PPE training available to workers in the facilities [ Time Frame: 4 weeks ]Compare the awareness of PPE training of the workers in the two arms, this is captured in self reported survey
- To compare the levels of PPE material used in [ Time Frame: 4 weeks ]Compare the amount of PPE used between the arms
- To compare the wellbeing and self-efficacy of the two groups [ Time Frame: 4 weeks ]Compare the wellbeing and self-efficacy between the two arms, this is captured in a self reported survey.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04377165
|Principal Investigator:||David L Paterson, PhD||The University of Queensland|